SEARCH NEWS & VIEWS


Hugh Rosen Makes Strides Toward New Treatments for MS, Flu and PTSD
TSRI and Takeda Pharmaceuticals Expand Collaboration
Institute Appoints Innovative Biotech Scientist to Cancer Biology Department

NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT




FOLLOW US

Etcetera


Sunitha Rangaraju Awarded Muscular Dystrophy Association Grant

Sunitha Rangaraju, a research associate at The Scripps Research Institute (TSRI) has been awarded a three-year development grant from the Muscular Dystrophy Association for her project, "Improving ALS phenotypes by targeting aging pathways."

Muscular Dystrophy Association development grants are awarded to “exceptional postdoctoral candidates who have the best chance of becoming independent researchers and future leaders of neuromuscular disease research,” according to the association’s website.

Amyotrophic lateral sclerosis (ALS) is a neuromuscular protein aggregation disease that progresses with age. Rangaraju, who works in the Petrascheck lab, will study whether small molecules that delay aging could also delay or improve ALS-like symptoms in worm and mice models.





Send comments to: mikaono[at]scripps.edu